Stem Cell Knee Injections: Do They Work — and Are They Worth It?

If a clinic has quoted you five figures for a stem cell knee injection — often pitched as the last exit before a knee replacement — give me two minutes first. As a pharmacist, this is a conversation I'm having across the counter more and more, and the straight version rarely matches the brochure.

Stem cell therapy is one of the most hyped and most expensive options on the whole joint-pain shelf. That doesn't make it a scam — the underlying biology is real and exciting. But there's a wide gap between what's promised in a consult room and what the evidence actually supports. Here's what these injections really are, what they can and can't do for a worn knee, and a far more affordable daily route worth understanding before you spend that kind of money: URAH Joint Health Omega-3, a transdermal glucosamine cream with peer-reviewed results behind it, now used in a growing number of hospital and clinic pharmacies.

At a Glance

Do stem cell knee injections work?

Across 25 randomised trials, stem cell injections may slightly improve knee pain and function compared with placebo. But the certainty remains limited, the average improvement may not be noticeable for everyone, and the preparations tested vary substantially from one study — and one clinic — to another.

The regulation picture

The FDA hasn't approved stem cell therapy for any orthopedic condition, including knee osteoarthritis. Different preparations fall under different rules, which is part of why quality and oversight vary so much from clinic to clinic.

The cost

Most patients pay several thousand dollars per knee, out of pocket — a US market survey found an average of about $5,156 for a single knee injection, though complex cultured or donor-cell protocols run much higher. Insurance rarely covers it.

The safety picture

Short-term, injection-site swelling and pain are the usual complaints, and serious events are uncommon in trials. The bigger unknowns are long-term safety and the wide quality gap between clinics.

Where URAH fits

Instead of a costly one-off bet on the joint's biology, URAH supplies glucosamine — the building block cartilage uses to maintain its own matrix — as an affordable daily routine, with a measured structural signal behind it.

Table of Contents

1. What Stem Cell Knee Injections Actually Contain

2. Do Stem Cell Injections Work for Knee Osteoarthritis?

3. Stem Cell Knee Injection Cost and FDA Status

4. Stem Cell Knee Injections vs Knee Replacement

5. Stem Cells vs PRP for Knee Pain

6. Safety and Recovery

7. Who's a Good Candidate?

8. What Else Actually Helps

9. A More Measured Place to Start

10. The Structural Signal Behind URAH

11. When to See a Doctor

12. FAQ

13. References

What Stem Cell Knee Injections Actually Contain

The sales pitch is simple: collect the cells your body uses to repair itself, concentrate them, and place them inside the worn joint — tapping the body's natural ability to heal. The reality is less cinematic.

"Stem cells" on a clinic website can mean several very different things:

• Bone marrow aspirate (BMAC) — drawn from your hip bone, then concentrated.

• Fat-derived cells (adipose / stromal vascular fraction) — harvested by liposuction, then processed.

• Umbilical cord or placental products — sold "off the shelf," and here's the catch: independent testing has found several of these contain few or no living cells by the time they're injected.

With the bone-marrow and fat versions, the sample is spun in a special machine called a centrifuge to concentrate the useful fraction — a mix that includes platelets, white blood cells, growth factors, and only a very small proportion of actual mesenchymal stem cells. In bone-marrow concentrate, that fraction is often under 0.01%. So how does stem cell therapy actually work? Researchers are still sorting out which part — the cells, the signaling molecules, or the anti-inflammatory effect — is doing the work.

Do Stem Cell Injections Work for Knee Osteoarthritis?

The most current, highest-quality answer comes from a 2025 Cochrane review — the closest thing medicine has to a neutral referee. Pooling 25 randomised trials and 1,341 patients, it found stem cell knee therapy may slightly improve knee pain and function versus a placebo injection, on low-certainty evidence — with the average improvement possibly too small for some people to notice, and no clear benefit for quality of life or overall treatment success. For someone living with chronic knee pain, a small, uncertain edge over placebo is worth hearing plainly.

The boundaries are big, and any pharmacist worth their salt will tell you them:

• The certainty is low — trials are small, short, and wildly inconsistent in how they prepare and dose the cells, and several were funded by the cell manufacturers.

• The products used in the trials often aren't what your local clinic injects, so results don't transfer cleanly to the syringe in front of you.

• In a 480-patient phase-3 trial (the MILES study), cell-based injections showed no clear advantage over a simple corticosteroid shot at one year — and steroids cost a tiny fraction as much.

• Professional bodies — the AAOS and the hip and knee surgeons' association (AAHKS) — don't recommend stem cell or PRP injections for knee osteoarthritis, citing insufficient evidence.

So it may help some people, a little, in the short term. It isn't a proven fix, and it doesn't reliably rebuild a worn joint.

Stem Cell Knee Injection Cost and FDA Status

This is where I put my pharmacist hat on firmly, because it's the bit that gets glossed over in the sales consult.

The FDA hasn't approved stem cell therapy for knees. In its consumer alert on regenerative products, the agency is blunt: these products aren't approved for the treatment of any orthopedic condition, such as osteoarthritis. The FDA-approved stem-cell products that do exist are blood-forming cells derived from umbilical cord blood, used for certain disorders of the blood-forming system — nothing for joints.

But "FDA-unapproved" doesn't mean "unregulated," and the difference is worth understanding. Stem-cell knee treatment sits in a confusing regulatory space: some same-day bone-marrow concentrates may be offered without premarket approval when they meet specific criteria, while culture-expanded and donor-cell products face a different, stricter level of FDA oversight. Real research runs under a strict protocol — ethics approval, standardized cells, tracked outcomes — and plenty of storefront clinics operate well away from that standard. That's why the words "stem cell injection" tell you surprisingly little about what's actually in the syringe.

Then there's the price. Stem cell knee therapy cost typically runs several thousand dollars per knee — a US market survey found an average of about $5,156 for a single knee injection, though complex cultured or donor-cell protocols climb much higher. Insurance rarely covers it, so most people pay cash, out of pocket, for something that isn't approved and isn't guaranteed to work.

That combination — unproven, expensive, and hard to vet — is why a lot of people, once they've done the reading, look for a more measured place to start.

→ See URAH Joint Health Omega-3 — the transdermal cream with a measured structural signal behind it. 60-day money-back guarantee.

Stem Cell Knee Injections vs Knee Replacement

A lot of people search stem cells hoping to dodge a knee replacement surgery, so let's be clear-eyed about it. Knee replacement is a proven, if major, operation with decades of outcome data — reliable for advanced, bone-on-bone arthritis, with a real recovery and rehab commitment. Stem cell injections are the opposite profile: minimal downtime, but unproven and expensive. They are not a proven substitute for a replacement. If a joint is truly bone-on-bone and a surgeon has recommended surgery, an unapproved injection isn't the thing to gamble your mobility on — and paying a small fortune to postpone a needed operation can mean delaying the thing that actually fixes the joint.

The better question is usually not "stem cells or surgery?" but "have I actually exhausted the proven, lower-risk steps in between?" — because most people haven't.

Stem Cells vs PRP for Knee Pain

The other injection people weigh this against is PRP. Both are drawn from your own body and spun down; the difference is what gets concentrated. Platelet-rich plasma injections concentrate platelets and growth factors — no stem cells — and a platelet-rich plasma injection has more (still mixed) trial evidence behind it for knee osteoarthritis, at a fraction of the cost. Stem cell injections concentrate cells, cost far more, and carry thinner, lower-certainty evidence. Neither rebuilds a worn joint. If you're set on trying an injection, PRP is often the more sensible first experiment — our PRP knee injections guide covers where it does and doesn't earn its keep.

Safety and Recovery

From your own body (bone marrow or fat), stem cell injections are reasonably well tolerated in the short term. Reviews find most side effects are temporary — swelling and pain at the injection site, usually settling within a few weeks, with most people back to light daily activities quickly, and serious adverse events uncommon in the trials to date.

The bigger unknowns are the long game and the quality gap between clinics. Solid three-to-five-year safety data is scarce, and with some clinics selling unproven or "off-the-shelf" products, the FDA has warned of harms at the unregulated end. If you do go ahead, ask exactly what's being injected and how it's prepared — and treat the absence of a straight answer as your answer.

Who's a Good Candidate?

If someone's set on exploring it, a reasonable good candidate looks like this: mild-to-moderate knee osteoarthritis (not end-stage, bone-on-bone), symptoms that haven't responded to solid conservative care, realistic expectations (symptom relief, not regrowth), and a clinic that can explain its cells, dose, and protocol. Beyond the knee, the same cells are marketed for ligament injuries and tendons — with the same evidence caveats. If you can't get straight answers on preparation and protocol, that tells you plenty.

What Else Actually Helps

Before anyone spends the price of a used car on an injection, the unglamorous stuff is where the real, proven returns on joint pain live:

• Physical therapy and targeted strengthening — the single most reliable long-term move for a worn knee.

• Weight loss where it applies — every pound off is roughly four fewer through the knee with each step.

• Sensible pain relief and staying active, guided by your doctor.

Done consistently, that's the foundation that keeps people mobile and out of the operating theatre for years.

A More Measured Place to Start

Before spending several thousand dollars on a one-off procedure, ask a simpler question: what are you doing every day to support the joint you still have?

Think of how people take collagen for their skin — skin has a structural matrix that changes with age, and so do your joints. Cartilage cushions the joint by holding water inside a springy scaffold of proteoglycans, and glucosamine is one of the building blocks that system uses, including for the joint's own hyaluronic acid. Your body produces glucosamine naturally — but as cartilage ages, its cells become less efficient at maintaining the proteoglycan-rich matrix, and the tissue's repair capacity declines, making consistent daily support increasingly relevant over time.

URAH takes that daily approach. Its Joint Health Omega-3 uses a micellar transdermal system to carry glucosamine through the skin and into the bloodstream, bypassing the oral route. It came out of a Singapore research lab, founded by scientist Dr. Jonathan Obaje, with the micellar delivery method patented in the US, Japan, and Singapore — it grew through clinical recommendation rather than advertising, and has been used in clinics for more than a decade, with over one million units sold worldwide, according to URAH. Support starts where you apply it, then circulation carries it further. Targeted first. Circulates further.

The Structural Signal Behind URAH

Here's what's been measured. In an independent, peer-reviewed 12-week knee osteoarthritis study, the group receiving URAH 8% glucosamine cream through massage showed an average 61% increase in medial joint space width — an indirect measure of cartilage thickness — moving in the opposite direction to the narrowing osteoarthritis normally brings. Separately, a clinical survey across 16 clinics in Singapore reported significantly reduced pain and improved quality of life in arthritis patients over four weeks.

On absorption, comparative bioavailability data reported by URAH measured blood glucosamine up to 10× higher through its micellar transdermal route than through the oral route — aimed straight at the delivery problem that held back oral glucosamine trials.

You can read the full study and its context on our Research & Evidence page.

→ Start with URAH Joint Health Omega-3 — ships worldwide with a 60-day money-back guarantee.

When to See a Doctor

Daily support is for the slow, everyday side of joint care — not for warning signs. See a doctor promptly if you have a joint that's suddenly hot, red, or swollen; a fever alongside joint pain; severe pain after an injury or fall; or a knee that locks, gives way, or won't take weight. And if a surgeon has recommended surgery, don't delay it for the sake of any injection or cream.

FAQ

Do stem cell injections work for knees?

The best current evidence — a 2025 Cochrane review of 25 trials — found they may slightly improve knee pain and function versus placebo, but on low-certainty evidence, and the improvement may be too small for some people to notice. The products in trials often differ from what clinics inject, and it's not shown to rebuild cartilage.

How much do stem cell knee injections cost?

Most patients pay several thousand dollars per knee, out of pocket — a US market survey found an average around $5,156 for a single injection, with complex cultured or donor-cell protocols costing more. Insurance rarely covers it.

Are stem cell injections FDA-approved for knees?

No. The FDA hasn't approved any stem cell product for orthopedic conditions like osteoarthritis. The only FDA-approved stem-cell products are blood-forming cells from cord blood, for certain blood-system disorders. Different preparations fall under different rules, so ask a clinic exactly what it's injecting and under what regulatory pathway.

Can stem cells help me avoid a knee replacement?

There's no good evidence they reliably replace surgery. If your knee is bone-on-bone and a surgeon recommends a replacement, don't delay it for an unproven injection. The better use of the pre-surgical window is consistent, low-risk daily joint support.

Stem cells vs PRP — which is better?

PRP has more trial evidence, costs far less, and carries fewer regulatory questions, though it's also inconsistent. Stem cell therapy is more expensive and less certain. Neither rebuilds a worn joint.

Is there a cheaper, lower-risk option?

Alongside physical therapy and weight management, a daily transdermal glucosamine routine like URAH is a fraction of the cost, carries a long safety record, and has a measured structural signal behind it.

Further Reading

• PRP Knee Injections: Do They Work — and Are They Worth the Cost?

• Hyaluronic Acid Knee Injections: Do the Gel Shots Actually Work?

• How to Avoid Knee Replacement Surgery: Non-Surgical Alternatives That Actually Work

References

1. U.S. Food & Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes (2020). (Not approved for any orthopedic condition, including osteoarthritis and knee pain.)

2. U.S. Food & Drug Administration. Approved Cellular and Gene Therapy Products. (Only approved stem-cell products are hematopoietic/cord-blood cells for blood-system disorders — none for orthopedic use.)

3. Whittle SL, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews. 2025;CD013342.pub2. (25 RCTs, 1,341 participants; low-certainty evidence of small improvement in pain and function vs placebo; no clear benefit for quality of life or treatment success.)

4. MILES study. Cell-based therapies vs corticosteroid injection for knee osteoarthritis. Nature Medicine. 2023 (480 participants; no cell-based preparation superior to corticosteroid injection at one year).

5. American Association of Hip and Knee Surgeons (with The Hip Society and The Knee Society). Biologics for Advanced Hip and Knee Arthritis (position statement), 2025. (BMAC preparations usually contain <0.01% mesenchymal stem cells; autologous BMAC not FDA-regulated while culture-expanded/donor products are; biologics not recommended for advanced hip/knee arthritis.)

6. Complications of stem cell–based injections for knee osteoarthritis: a systematic review. 2021 (48 studies, 1,924 patients; ~12.3% transient adverse events, predominantly injection-site swelling/pain; long-term data limited).

7. Berger DR, et al. Analysis of commercial umbilical cord and amniotic "stem cell" products. 2021. PMID 34398643. (Several marketed products contained few or no viable cells.)

8. Onigbinde AT, et al. Symptoms-modifying effects of electromotive administration of glucosamine sulphate among patients with knee osteoarthritis. Hong Kong Physiotherapy Journal. 2018;38(1):63–75. (Massage group receiving URAH 8% glucosamine cream showed ~61% increase in medial joint space width; full context on the URAH Research & Evidence page.)

9. Ng Guat Hua, Lee Yu Ming, Obaje J. A Transdermal Glucosamine Formulation Improves Osteoarthritic Symptoms in an Open Clinical Survey. (16-clinic Singapore survey; reduced pain and improved quality of life over four weeks.)

This article is for general information and education, and isn't a substitute for professional medical advice. It does not claim that any product cures, reverses, or regrows cartilage. Always check with your healthcare professional before starting any supplement or changing your treatment, and don't delay recommended care.